Lv1
80 积分 2023-09-12 加入
From TCR fundamental research to innovative chimeric antigen receptor design
3个月前
已完结
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of the LVIVO-TaVec100 Product in the Treatment of Relapsed/Refractory B-cell Malignancies
4个月前
已关闭
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
4个月前
已关闭
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
4个月前
已完结
Noncanonical and mortality-defining toxicities of CAR T cell therapy
7个月前
已完结
Mechanisms of Endocytosis
7个月前
已完结
皖公网安备34019202002308
